Newsroom

The latest news and stats on sleep apnea and respiratory care from
ResMed, the world's leading tech-driven medical device company. 

ResMed named "JUST 100" top U.S. corporate citizen 2 years in a row

Read the press release

Latest news

Latest news

December 12, 2017

SAN DIEGO – December 12, 2017 – ResMed today was named one of America’s top 100 corporate citizens for the second straight year by Forbes and JUST Capital, a nonprofit that analyzes and...

December 6, 2017

SAN DIEGO – December 6, 2017 – ResMed has been named a 2017 “Medtech Company of the Year” finalist by MD+DI, a leading news resource in the medical device and diagnostic industry....

November 21, 2017

SAN DIEGO – November 21, 2017 – CHEST, the publication of the American College of Chest Physicians, has published a ResMed study that shows patient engagement apps significantly improve...

See all news releases

Fast facts - Landing Page

Fast facts

  • 1,300
    CPAP users a day sign up for myAir to self monitor their treatment.
  • +4 MILLION
    people remotely monitored on cloud connected CPAP machines and ventilators every night.
  • +12 MILLION
    lives changed by a ResMed device, mask or accessory.

See all fast facts

Infographics - Landing Page

Infographics

Learn about respiratory conditions, their effects on our health and communities,
and how ResMed helps millions live and breathe better.

 

See all infographics

Media resources - Gray, Left - Landing Page

Media resources

Find everything you need.
Ask us for more information.

See all resources

Media contacts - Gray, Right - Landing Page

Media contacts

Global

Alison Graves
(858) 836-6789

 

Americas

Jayme Rubenstein
(858) 836-6798

 

EMEA, Japan

Juliette Lambert
(33) 646-621-241

 

Asia-Pacific

Paul McKeon
(61) 2-8884-2596

 

Questions? Site Feedback?

Email us

Email Alerts - Landing Page

Sign up to receive ResMed news releases when they publish.

Subscribe

 

ResMed provides a non-transferable, non-exclusive license to the copyrighted images, drawings and materials subject to the following Terms of Use.

All countries & languages